met inhibitors (Ontogen)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug Namemet inhibitors (Ontogen)
Drug Alias Nameangiogenesis inhibitor (Ontogen)antitumor agents (Ontogen)hepatocyte growth factor antagonist (Ontogen)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHepatocyte growth factor receptor inhibitors
TargetsHepatocyte growth factor receptor
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesOntogen
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesOntogen
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A